Cordis Precise, Guidant Acculink Are First “Approvable” Carotid Stents
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson/Cordis and Guidant are working to satisfy FDA's remaining conditions for approval of their respective Precise and Acculink carotid stent systems, as outlined in recent "approvable" letters
You may also be interested in...
Carotid Stenting Stroke Is Not Caused Solely By Emboli – VEITH Panelist
Hemodynamic events, in addition to embolic obstructions, are responsible for injuries to the brain associated with carotid artery stenting, according to Sumaira Macdonald, PhD, Freeman Hospital, Newcastle-on-Tyne, UK
Carotid Stenting Stroke Is Not Caused Solely By Emboli – VEITH Panelist
Hemodynamic events, in addition to embolic obstructions, are responsible for injuries to the brain associated with carotid artery stenting, according to Sumaira Macdonald, PhD, Freeman Hospital, Newcastle-on-Tyne, UK
Blues TEC Assessment Less Enthusiastic About Carotid Stents Than CMS
Existing data on carotid stenting with distal embolic protection fail to demonstrate that the procedure produces better outcomes than surgery, BlueCross BlueShield Association's Technology Evaluation Center concluded Feb. 10